Tweets
We are excited to announce that Dr. Philip Mease will be joining us at RheumNow Live, leading a presentation and discussion on Axial Psoriatic Arthritis & Fatigue and Central Sensitization.
Join the discussion on March 19-20, on site or virtually!
https://t.co/3CeULLDgf5 https://t.co/M2ZUoXzlAK
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
ICYMI: Top Tweet in January
Clinical trials generally fail in Sjögren's syndrome; but now a study shows that a biologic B cell inhibitor, ianalumab, met its primary endpoint with a dose-related decrease in disease activity (measured by ESSDAI) at week 24.
https://t.co/SLn2qs8En4 https://t.co/nMOUm2C9It
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
TB is uncommon in idiopathic inflamm myopathies (3.58%), esp in endemic areas (eg, Asia). Disseminated and Extra-pulmonary (47%) was as common as pulmonary TB (49%); TB Muscle dz seen in 24%. More with M. TB than Non-tuberculous Mycobacteria https://t.co/h6uDsdWj3f
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Retrospective study of 84 pts with Erosive Hand OsteoArthritis (EHOA)- 89% females DIPs erosions scores were higher than PIP’s. Comorbid dz = crystal arthritis (8%), RA (5%) & PsA (1%), Pain usually >5/10 w/ 1/3 responding to NSAIDs. Big Unmet need! https://t.co/jQ3yNgaZBA
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Treatment of Complex regional pain syndrome type-I (CRPS-I) in adults is difficult! A Systematic review shows that only parenteral bisphosphonates (and maybe ketamine) lowered VAS/NRS pain scales vs placebo. https://t.co/m4SpO4P96J
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Persons living with diagnosed HIV (PLWDH) have more hospitalizations and death from COVID-19 than those not HIV+. In 100K PLWDH, 63%) were fully vaccinated, 4% partly Vax & 32% no Vax. VAX in PLWDH was lower than gen population (63% vs 75%) https://t.co/oegf5WjmNF
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
In the USA, the prevalence of Vitiligo in adults is between 0.76% (1.9 million cases in 2020) and 1.11% (2.8 million cases in 2020). Approximately 40% of adult vitiligo in the US may be undiagnosed. https://t.co/rsyoIbHmS8
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Radiographic progression in AxSpA studied in 101 Spanish Pts - pts w/ sustained low ASDAS had less XRay progression than those with active Dz (2.33 vs 1.76, p=0.027). Long term TNFi use didnt influence progression until the 3rd Yr https://t.co/KHCdzbqhzr
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
FDA has expanded its approval of REMDESIVIR for use in non-hospitalizedadults and pediatric patients for the treatment of mild-to-moderate COVID-19 disease. Previously, Veklury was limited to hospitalized COVID-19 pts. https://t.co/dHbomchfB5
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Interested in our most popular articles? Head over to RheumNow.
https://t.co/8JLpph3or8
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Finnish Parkinson’s disease (FINPARK) cohort (22,189) looked at the assoc w/ #RA. RA pts using only chloroquine/hydroxychloroquine was associated with a lower risk of developing PD (adjusted OR 0.74); not with other DMARDs https://t.co/yZhgVT0xLh
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
Systematic review of GI Safety of IL-17 inhibitors included 106 RCTs and 40,053 patients. Inflammatory bowel disease occurred in 0.4%; Most freq Sxs - diarrhea (2.5%), nausea or vomiting (0.7%), and gastroenteritis (0.2%). https://t.co/tv3QXHU1Hg
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 5 months ago
